Burjeel Holdings IPO
Burjeel Holdings is a leading MENA private healthcare services provider known for its quality and clinical excellence, operating an integrated network of hospitals and medical centers across the UAE and Oman.
How To SubscribeOur
Story
On 12 September 2022, Burjeel Holdings announced its intention to float on the Abu Dhabi Securities Exchange (ADX). This section of our website, Our IPO, contains more information about our business, our planned Initial Public Offering (IPO) and the steps you need to take to participate in the IPO. Founded in 2007, Burjeel Holdings is a leading MENA private healthcare provider, operating as an integrated network across primary, secondary, tertiary and quaternary care. With a network of 39 hospitals and medical centers, Burjeel Holdings is the largest private healthcare provider in the UAE by numbers of beds and number of doctors employed. Burjeel Holdings has an in-patient market share of approximately 17%¸the leading position in the UAE, and an out-patient market share of approximately 12%. Burjeel Holdings had a total bed capacity of 1,316 beds as at 30 June 2022. Across our healthcare brands, Burjeel, Medeor, LLH, Lifecare and Tajmeel, Burjeel Holdings treated 105,000 in-patients and 4.3 million out-patients in 2021.

Key Milestones in our Growth
2007
Test
2008
LLH Hospital, Musaffah
Launched our multi-specialty hospital to provide affordable care in the industrial district of Musaffah, Abu Dhabi.
2012
Lifecare Hospital, Baniyas
Launched our multi-specialty hospital to offer medical care in the industrial area of Abu Dhabi.
2013
Tajmeel Kids Park Medical Center, Abu Dhabi
Launched our premier medical center to provide comprehensive medical care for children and adolescents.
2015
Medeor Hospital, Abu Dhabi & Dubai
Opened two multi-specialty hospitals offering affordable, quality healthcare in a friendly environment.
2017
Burjeel Day Surgery Center, Abu Dhabi
Launched our day surgery center designed to help patients get back to their lives quickly and comfortably.
2019
Burjeel Specialty Hospital, Sharjah
Launched our multi-specialty hospital to provide the highest level of care and comfort to the people of the Sharjah region.
2022
Burjeel Farha, Al Ain
Launched the first comprehensive fetal medicine center in the region for diagnosing and treating fetal disorders.
2022
Announced Kingdom of Saudi Arabia expansion
Announced our MoU with the KSA Ministry of Investment and our intention to seek opportunities to invest up to USD $1.0 billion in KSA by 2030.
2007
LLH Hospital, Abu Dhabi
Launched our multi-specialty hospital providing affordable care in Abu Dhabi.
2012
Burjeel Hospital, Abu Dhabi
Launched our quaternary care multi-specialty hospital in Abu Dhabi.
2013
Burjeel Hospital for Advanced Surgery, Dubai
Launched our advanced microsurgery and orthopedic center, providing access to advanced care in the UAE.
2014
Lifecare Hospital, Musaffah
Launched our multi-specialty hospital to offer medical care in the industrial area of Abu Dhabi.
2016
Tajmeel Specialized Medical Center, Abu Dhabi
Launched our premier medical center offering dermatology, dental and pediatric services.
2018
Burjeel Royal Hospital, Al Ain
Launched our luxurious, state-of-the-art healthcare facility to provide the most advanced medical care.
2020
Burjeel Medical City, Abu Dhabi
Launched our world-class quaternary care hospital providing extensive medical services in a luxurious environment.
2022
Kypros Nicolaides Fetal Medicine & Therapy Center
Launched the first comprehensive fetal medicine center in the region for diagnosing and treating fetal disorders.
Our
Brands



Investment
Highlights
Burjeel Holdings provides a comprehensive healthcare ecosystem to patients across the full socio-economic spectrum under the Burjeel, Medeor, LLH, Lifecare and Tajmeel brands, each of which is positioned to serve a different target market demographic.
Key
Metrics
as of September 16, 2022AED 3,924m
Revenue (FY 22)
AED 878m
EBITDA (FY 22)
AED 355m
Net Profit (FY 22)
23
Medical Centers
16
Hospitals
5.6m
Patients Treated
Our
Leadership

Dr. Shamsheer Vayalil
Chief Executive Officer and Executive Director
Dr. Shamsheer Vayalil is the Founder and CEO of Burjeel Holdings, the leading healthcare provider in the UAE. An entrepreneur and philanthropist, Dr. Shamsheer set up the first hospital, LLH Hospital, in Abu Dhabi in 2007 to address a gap in top-quality tertiary care in the UAE. In the last 15 years, Dr. Shamsheer has tirelessly worked to build one of the largest and most dynamic healthcare companies in the Gulf and the Middle East. Through Dr. Shamsheer’s vision and strategy, Burjeel Holdings swiftly expanded into diverse brands comprising hospitals, medical centers, homecare and occupational health, and retail pharmacies. During the COVID-19 pandemic, Dr. Shamsheer and Burjeel Holdings have been at the forefront of mobilizing advanced healthcare protocols and conducting PCR tests across the UAE, Oman, and India. Under his leadership, Burjeel Holdings has conducted more than 2 million PCR tests, administered over half a million vaccines, and treated over 10,000 in-patients across the UAE and Oman for COVID-19. As the medical partner for the Indian Premier League in 2020 and 2021, and the T20 World Cup in the UAE, Burjeel Holdings successfully maintained the bio-bubble during the tournaments. Dr. Shamsheer has received numerous global and local awards for his continuous pursuit of excellence in developing healthcare, philanthropy, and entrepreneurship across the region. He is the recipient of the Pravasi Bharatiya Samman Award, India’s highest civilian award presented to Non-Resident Indians, and is among the first investors to receive a long-term residency in the UAE and Oman. Dr. Shamsheer is a member of the UAE Medical Council and a member of the advisory committee of the University of Sharjah College of Medicine. Born in Kozhikode in the south Indian state of Kerala, Dr. Shamsheer pursued an MBBS and MD in radiology in India. Growing up in a family environment in his native Kerala, Dr. Shamsheer attributes his inclination for philanthropy to the value system fostered by his parents, where doing charity is an inherent part of the family. He hopes his philanthropic efforts will make a deep impact on public health globally and inspire other young entrepreneurs to follow suit.





















Sustainability
“Driven by our pursuit to deliver high-quality and accessible healthcare, we have placed sustainability at the heart of our decision-making framework. We continually strive to enhance the positive impact of our operations and deliver long-term value for all our stakeholders.” – By Dr. Shamsheer Vayalil, Chief Executive Officer and Executive Director.
Burjeel Holdings is committed to improving its ESG performance, implementing initiatives and making investments that elevate the performance of its businesses, while reducing environmental impacts, adding value to its communities and employees, and ensuring strong governance across the business.
IPO
Timeline
14 September 2022
ITF announcement
6 October 2022
Closing date of the first tranche (retail investors)
10 October 2022
Announcement of final offer price
13 October 2022
Commencement of subscriber refunds
26 September 2022
Subscriptions open and price range announcement
7 October 2022
Closing date of the second tranche (professional investors)
13 October 2022
SMS confirmation to all successful subscribers
14 October 2022
Expected date of listing the shares on ADX
How to
Subscribe?
To subscribe to the Burjeel Holdings IPO please follow the below steps. Further detailed information can be found in the prospectus.
Make sure you have your ADX Investor Number (NIN)
If you don’t have a NIN, you can register for one instantly with your UAE Pass through the ADX SAHMI app or by calling the ADX call center on 800239. If you are unsure whether you already have a NIN, please call ADX customer service center on 800239 or email callcenter@adx.ae.
Read the Prospectus document
Review the content and documents on this IPO webpage to get more information about the company and its initial public offering. The Prospectus document provides all material information about the company and the IPO.
Make an informed decision
Once you have familiarized yourself with the company, you can make an informed investment decision.
Subscribe to the Offering
If you have decided that you would like to invest, subscribe to the offering through one of the Receiving Banks. Each Receiving Bank will have its own channels, which typically include online, in a branch or through your bank relationship manager. The list of receiving banks and their details can be found further down this page, and in the Prospectus document.
Allocation of Shares
You will be notified of the number of shares allocated to you. You may or may not receive the full allocation of your order. Any excess funds will be refunded to you.
Frequently Asked
Questions
For further information, please refer to the full list of FAQs under the IPO Documents & Download's section.
Contact
Us
Registered office
402-DO2
15th Floor
Al Sarab Tower
Abu Dhabi Global Market Square
Al Maryah Island, Abu Dhabi
United Arab Emirates
ADX
Emirates NBD Bank PJSC
800 BURJ IPO (800 2875 476)
Investor Relations Enquiries
Chetan Sehgal
Head of Investor Relations
ir@burjeelholdings.com
+971 (0) 230 4111
Media Enquiries
Andy Parnis
Managing Director – Teneo
Andy.parnis@teneo.com
+971 (0) 58 581 4954